Biosite Diagnostics Inc., Eos Biotechnology, Medarex deal

Eos will use antibodies developed with BSTE’s phage-display and MEDX’s HuMAb antibody

Read the full 126 word article

How to gain access

Continue reading with a
two-week free trial.